EBOS Group stock falls 1.83% as NZX ends week lower

Published on 11/13/2026 at 20:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EBOS Group stock fell on the NZX on Friday as the broader market retreated. BusinessDesk cited higher bond yields and oil prices as market headwinds.

What moved EBOS Group stock

EBOS Group fell on the NZX as New Zealand equities ended the week lower.
BusinessDesk cited higher bond yields and oil prices as factors slowing market trading.
EBOS Group operates across healthcare, pharmaceuticals and animal care in Australasia.

EBOS Group stock, NZX, New Zealand shares, healthcare distribution, market close, Illustration mit AI erstellt.

EBOS Group stock fell on the NZX on Friday, November 13, as New Zealand equities ended the week lower. BusinessDesk reported that the healthcare distributor declined NZD 0.40, or 1.83 percent, to NZD 21.40. The S&P/NZX 50 Index closed down 0.6 percent at 14,173.68.

The market report attributed the softer session to rising bond yields and oil prices, which renewed inflation concerns and slowed trading. The main board recorded 54 gainers and 73 decliners, according to BusinessDesk.

EBOS business and investor calendar

EBOS Group markets, wholesales and distributes healthcare, medical and pharmaceutical products across Australasia. It also markets and distributes animal care brands, according to the company's investor information.

The company lists annual and interim reports, investor announcements, dividend information and presentations among its investor resources. Its investor calendar says more events are coming soon.

EBOS Group stock traded at 10.80 euros on Lang & Schwarz at 8:18 p.m. CET on Friday, November 13, 2026.